Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades

Stock Track05-15

Tango Therapeutics Inc. (TNGX) experienced a significant pre-market plunge of 9.73% on Friday, as the stock came under selling pressure following a series of analyst rating downgrades.

The sharp decline was triggered by Piper Sandler's decision to cut its rating on Tango Therapeutics to Neutral from Overweight, despite simultaneously raising its price target to $24 from $16. Additionally, Jefferies also downgraded the stock, moving its rating to Hold from Buy.

These analyst actions reflect a shift in sentiment towards the biotechnology company, suggesting reduced optimism about its near-term prospects. While one firm did raise its price target significantly, the overall downgrade in ratings appears to have outweighed that positive adjustment in the pre-market session, leading to the substantial sell-off.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1133387200?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-15 16:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1133387200","market":"sg","top_or_hot":-1,"title":"Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades","media":"Stock Track","content":"<p>Tango Therapeutics Inc. (TNGX) experienced a significant pre-market plunge of 9.73% on Friday, as the stock came under selling pressure following a series of analyst rating downgrades.</p><p>The sharp decline was triggered by Piper Sandler's decision to cut its rating on Tango Therapeutics to Neutral from Overweight, despite simultaneously raising its price target to $24 from $16. Additionally, Jefferies also downgraded the stock, moving its rating to Hold from Buy.</p><p>These analyst actions reflect a shift in sentiment towards the biotechnology company, suggesting reduced optimism about its near-term prospects. While one firm did raise its price target significantly, the overall downgrade in ratings appears to have outweighed that positive adjustment in the pre-market session, leading to the substantial sell-off.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Tango Therapeutics Plunges 9.73% in Pre-Market on Analyst Downgrades\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-05-15 16:28</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tango Therapeutics Inc. (TNGX) experienced a significant pre-market plunge of 9.73% on Friday, as the stock came under selling pressure following a series of analyst rating downgrades.</p><p>The sharp decline was triggered by Piper Sandler's decision to cut its rating on Tango Therapeutics to Neutral from Overweight, despite simultaneously raising its price target to $24 from $16. Additionally, Jefferies also downgraded the stock, moving its rating to Hold from Buy.</p><p>These analyst actions reflect a shift in sentiment towards the biotechnology company, suggesting reduced optimism about its near-term prospects. While one firm did raise its price target significantly, the overall downgrade in ratings appears to have outweighed that positive adjustment in the pre-market session, leading to the substantial sell-off.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TNGX","symbol_name":"Tango Therapeutics Inc.","start_time":0,"source_url":"","article_id":"1133387200","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1133387200","pubTimestamp":1778833680,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Tango Therapeutics Inc. (TNGX) experienced a significant pre-market plunge of 9.73% on Friday, as the stock came under selling pressure following a series of analyst rating downgrades.The sharp...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"TNGX":"Tango Therapeutics Inc."},"translate_title":"个股追踪|分析师下调评级Tango Therapeutics盘前暴跌9.73%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"TNGX":1},"content_text":"Tango Therapeutics Inc. (TNGX) experienced a significant pre-market plunge of 9.73% on Friday, as the stock came under selling pressure following a series of analyst rating downgrades.The sharp decline was triggered by Piper Sandler's decision to cut its rating on Tango Therapeutics to Neutral from Overweight, despite simultaneously raising its price target to $24 from $16. Additionally, Jefferies also downgraded the stock, moving its rating to Hold from Buy.These analyst actions reflect a shift in sentiment towards the biotechnology company, suggesting reduced optimism about its near-term prospects. While one firm did raise its price target significantly, the overall downgrade in ratings appears to have outweighed that positive adjustment in the pre-market session, leading to the substantial sell-off.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1133387200","isCrawlerRequest":true}